Find an Article

Filter articles

Applied Filters

Showing 71 to 80 of 288 results

Uncertain times for antibodies in India

India31-05-2018Archana Shanker and Nupur Maithani

In India, there are two core areas of the antibody patenting field that are unsettled and need correcting, as Archana Shanker and Nupur Maithani of Anand and Anand explain.

Patents and biodiversity: crossing the divide

India15-05-2018Vidisha Garg

The Indian Patent Office has attempted to bridge the divide between the laws on patents and biological diversity, but instead it created a maze of problems, says Vidisha Garg of Anand and Anand.

Clearing a way through the CRISPR patent jungle

Belgium, Denmark, International08-05-2018Timo Minssen, Esther van Zimmeren, Jakob Wested

There may be a path through the CRISPR patent jungle, but there are many obstacles still in the way, say European academics Timo Minssen, Esther van Zimmeren and Jakob Wested.

Conference preview: ChinaBio Partnering Forum


The ChinaBio Partnering Forum, which will be held in Suzhou from April 25 to 26, is celebrating its tenth anniversary and is expected to attract pharma and biotech companies from around the world.

Conference preview: BIO-Europe Spring


The 12th annual BIO-Europe Spring conference, to be held in Amsterdam, the Netherlands on March 12 to 14, 2018, will allow key players in the biotech industry to come together, as Catherine Moreno Finan reports.

A helping hand for rare diseases


Companies researching and commercialising drugs for rare diseases face unusual challenges in protecting their inventions, as Michael Yamauchi, director and patent counsel at Alexion Pharmaceuticals, tells LSIPR in an interview.

LSIPR 50 2017: Leda Trivinos—Playing the long game


Thinking about how IP can assist a company long before it has fully developed is essential, says Leda Trivinos of Flagship Pioneering in an interview with LSIPR.

LSIPR 50 2017: James Topper—Venturing into biotech


Frazier Healthcare Partners has been responsible for creating and investing in multiple biotech companies, developing products from novel antibiotics to cancer therapies. James Topper, Frazier’s managing general partner, explains the firm’s philosophy.

LSIPR 50 2017: Arabella Cecil—No more hand to mouth


BACIT, a former fund of funds, has combined with life sciences investment company Syncona to form a new investment vehicle using the latter’s name. LSIPR speaks to Arabella Cecil, one of the co-founders of BACIT, about the new company’s vision.

LSIPR 50 2017: Larry Coury—The art of successful litigation


Resolving complex legal disputes and explaining technical concepts in a courtroom are all part of the job for Regeneron’s Larry Coury, who talks to LSIPR about life as senior director of dispute resolution.

Showing 71 to 80 of 288 results